NOCICEPTIN(170713-75-4)
- Name: NOCICEPTIN
- Synonyms:OrphaninFQ (pig);24: PN: US20030045696 SEQID: 24 unclaimed sequence;42: PN: WO2009012472 SEQID:42 unclaimed sequence;44: PN: WO2006068768 SEQID: 42 claimed sequence;46: PN:WO2007138339 SEQID: 38 claimed sequence;52: PN: WO2008008805 SEQID: 53unclaimed protein;730: PN: US20090175821 SEQID: 919 claimed protein;86: PN:WO03097857 PAGE: 39 claimed protein;87: PN: WO03097857 PAGE: 39 claimedprotein;9: PN: WO2008052043 SEQID: 8 claimed protein;Human nociceptin;L-Glutamine, L-phenylalanylglycylglycyl-L-phenylalanyl-L-threonylglycyl-L-alanyl-L-arginyl-L-lysyl-L-seryl-L-alanyl-L-arginyl-L-lysyl-L-leucyl-L-alanyl-L-asparaginyl-;Nociceptin;Nociceptin (human);Nociceptin(1-17)-OH;Orphanin FQ;Orphanin FQ(human);Orphanin FQ (rat);Orphanin FQ/Nociceptin, human, mouse, ox, rat;
- Molecular Formula:C79H129 N27 O22
- Molecular Weight:1809.06
- CAS Registry Number:170713-75-4
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 2823-91-8/N-(4-fluoro-9H-fluoren-2-yl)acetamide
- 30674-32-9/(22E)-24,24-Dimethyl-5α-chola-7,22-diene-3β-ol
- 33500-23-1/5-Hydroxy-4'-methoxy-7-methylflavone
- 75268-72-3/Tetrasodium 5,5-(iminobis((1-hydroxy-3-sulphonato-6,2-naphthylene)azo(2,5-dimethoxy-4,1-phenylene)azo))bis(salicylate)
- 122548-04-3/halocyamine B
- 22256-74-2/(Z)-N-Methyl-N-(1-oxo-9-octadecenyl)glycine, compound with morpholine (1:1)
- 13314-97-1/1-(morpholin-4-ylmethyl)pyrrolidine-2,5-dione
- 101564-31-2/phenyl(2-piperidin-1-ylcyclohexyl)methyl acetate hydrochloride
- 33456-21-2/1-[benzyl(methyl)amino]-3-[3-(3-methylpiperidin-1-yl)propyl]-3-phenyl-1,3-dihydro-2H-indol-2-one
- 82766-40-3/3,7-dimethyl-6-octenyl 3,7-dimethyloct-6-enoate
- 42226-53-9/1H-Dibenzo[a,i]carbazole
- 64426-01-3/N-tert-butyl-N-[(2,2-dimethylaziridin-1-yl)methyl]-2-methylpropan-2-amine
- 25165-45-1/barium pentafluoroaluminate
- 64803-75-4/4-octyltetrahydro-2H-thiopyran 1,1-dioxide
- 2403-50-1/p-Anisaldehyde ethylene acetal
- 2051-97-0/1-BENZYLPYRROLE
- 92327-27-0/3-[2-(dimethylamino)ethyl]-5-methyl-5-phenylimidazolidine-2,4-dione
- 118398-99-5/N-methyldiazenylethanamine
- 99908-88-0/6-(3,4-dichlorophenoxy)-3-(ethylthio)-2-pyridinecarbonitrile
- 170713-75-4/NOCICEPTIN
- 79771-10-1/Formaldehyde, polymer with (chloromethyl)oxirane and 4,4-(1-methylethylidene)bisphenol, reaction products with N-butylbutanamine and diethanolamine
- 965-09-3/N-(2-bromo-4-nitrophenyl)benzenecarbohydrazonoyl bromide
- 4433-08-3/DEHYDRODIEUGENOL
- 74746-57-9/7-(delta-hydroxybutyl)guanosine
- 139367-82-1/sceptrumgenin 3-O-lycotetraoside
- 78778-28-6/[(4S,4aR,8aR)-2-[3-(4-fluorophenoxy)propyl]-4-hydroxyoctahydroquinolin-1(2H)-yl]carbamic acid
- 91051-46-6/Fatty acids, rape-oil, hydrogenated
- 5631-55-0/4-acetyl-2-methoxyphenyl 3,5-dinitrobenzoate
- 522-90-7/Indolo[2,3-a]quinolizine-2-acetic acid,3-ethenyl-1,2,3,4,6,7,12,12b-octahydro- R-(methoxymethylene)-,(RE,2S,3R,12bS)-
- 73657-71-3/1-benzyl-3-ethyl-1,2,5,6-tetrahydropyridine-2-carbonitrile